Aehr Test Systems (AEHR) Key Metrics
AEHR valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.98B
- Enterprise value
- $3.08B
- P/E (TTM)
- — 10-yr median 45.4
- Forward P/E
- 126.6
- PEG ratio
- 0.92
- Price / sales
- 39.6 10-yr median 4.3
- Price / book
- 14.5 10-yr median 3.8
- EV / EBITDA
- 29.8 10-yr median 29.9
- Dividend yield
- —
- Beta
- 3.48
AEHR key metrics, FY2017–FY2026
Fiscal year ended May 31, 2026 · U.S. dollarsAEHR valuation Price multiples at each fiscal year-end price.
Price / sales+1,083.4%
56.6
FY2026 · hover or tap a bar for each year
FY2017FY2026
Price / book+461.7%
12.9
FY2026 · hover or tap a bar for each year
FY2017FY2026
Free cash flow yield+4.2 pts
−0.2%
FY2026 · hover or tap a bar for each year
FY2017FY2026
AEHR returns How much profit the business earns on the capital it uses.
Return on equity−0.8 pts
−4.2%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Return on invested capital−6.2 pts
−10.1%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Return on assets−0.8 pts
−3.6%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Free cash flow margin+10.3 pts
−10.8%
FY2026 · hover or tap a bar for each year
FY2017FY2026
Asset turnover−40.7%
0.25
FY2026 · hover or tap a bar for each year
FY2017FY2026
AEHR per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−18.2%
$1.63
FY2026 · hover or tap a bar for each year
FY2017FY2026
Earnings per share
−$0.23
FY2026 · hover or tap a bar for each year
FY2017FY2026
Free cash flow per share
−$0.18
FY2026 · hover or tap a bar for each year
FY2017FY2026
Book value per share+72.3%
$7.16
FY2026 · hover or tap a bar for each year
FY2017FY2026
Shares outstanding+3.7%
30.7M
FY2026 · hover or tap a bar for each year
FY2017FY2026
AEHR financial health Debt, liquidity and how easily interest is covered.
Debt / equity−48.9%
0.05
FY2026 · hover or tap a bar for each year
FY2017FY2026
Net debt−$92.1M
−$106.5M
FY2026 · hover or tap a bar for each year
FY2017FY2026
Current ratio+82.0%
10.33
FY2026 · hover or tap a bar for each year
FY2017FY2026
Debt / assets−45.1%
0.04
FY2026 · hover or tap a bar for each year
FY2017FY2026
AEHR efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+43 days
129 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Days of inventory+56 days
470 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Days payables outstanding+13 days
76 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Cash conversion cycle+86 days
523 days
FY2026 · hover or tap a bar for each year
FY2017FY2026
Capex / revenue−4.3 pts
4.1%
FY2026 · hover or tap a bar for each year
FY2017FY2026
AEHR valuation history
Fiscal year-endToday10-year median
AEHR returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
AEHR debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
AEHR cash returned to shareholders
DividendsBuybacksFree cash flow
AEHR price vs earnings per share
Share price at year-endEPS (right axis)
AEHR key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $2.83B | $282.2M | $340.9M | $964.7M | $232.7M | $52.8M | $37.8M | $39.2M | $59.2M | $74.5M |
| Enterprise value | $2.73B | $267.8M | $297.9M | $923.1M | $202.3M | $53.0M | $36.3M | $33.7M | $48.5M | $62.9M |
| P/E ratio | — | — | 10.3 | 66.3 | 24.6 | — | — | — | 112.2 | — |
| Price / sales | 56.6 | 4.8 | 5.1 | 14.9 | 4.6 | 3.2 | 1.7 | 1.9 | 2.0 | 3.9 |
| Price / book | 12.9 | 2.3 | 3.1 | 12.8 | 4.6 | 4.6 | 2.7 | 2.5 | 3.1 | 4.4 |
| Price / free cash flow | — | — | 338.5 | 111.5 | 213.1 | — | — | — | — | — |
| Price / operating cash flow | — | — | 194.1 | 96.4 | 154.3 | — | — | — | — | — |
| EV / sales | 54.5 | 4.5 | 4.5 | 14.2 | 4.0 | 3.2 | 1.6 | 1.6 | 1.6 | 3.3 |
| EV / EBITDA | — | — | 21.6 | 66.8 | 20.5 | — | — | — | 38.2 | — |
| EV / free cash flow | — | — | 295.9 | 106.7 | 185.2 | — | — | — | — | — |
| Earnings yield | −0.3% | −1.4% | 9.7% | 1.5% | 4.1% | −3.8% | −7.4% | −13.4% | 0.9% | −7.6% |
| Free cash flow yield | −0.2% | −4.4% | 0.3% | 0.9% | 0.5% | −5.5% | −5.8% | −14.8% | −3.2% | −6.7% |
| Dividend yield | — | — | — | — | 0.6% | 2.7% | 4.4% | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 0.1% | 0.3% | 0.5% | 0.2% | 0.8% | 2.7% | 4.5% | 0.0% | 0.0% | 0.0% |
| Share price at fiscal year-end | $92.33 | $9.54 | $11.51 | $33.02 | $8.38 | $2.25 | $1.65 | $1.75 | $2.60 | $4.58 |
| Per share | ||||||||||
| Revenue per share | $1.63 | $1.99 | $2.24 | $2.22 | $1.83 | $0.71 | $0.97 | $0.94 | $1.30 | $1.16 |
| Earnings per share | −$0.23 | −$0.13 | $1.12 | $0.50 | $0.34 | −$0.09 | −$0.12 | −$0.23 | $0.02 | −$0.35 |
| Operating cash flow per share | −$0.11 | −$0.25 | $0.06 | $0.34 | $0.05 | −$0.12 | −$0.09 | −$0.25 | −$0.06 | −$0.28 |
| Free cash flow per share | −$0.18 | −$0.42 | $0.03 | $0.30 | $0.04 | −$0.12 | −$0.10 | −$0.26 | −$0.08 | −$0.31 |
| Cash per share | $3.79 | $0.85 | $1.66 | $1.64 | $1.13 | $0.20 | $0.24 | $0.24 | $0.74 | $1.09 |
| Book value per share | $7.16 | $4.15 | $3.77 | $2.59 | $1.84 | $0.49 | $0.62 | $0.69 | $0.85 | $1.03 |
| Tangible book value per share | $6.50 | $3.43 | $3.77 | $2.59 | $1.84 | $0.49 | $0.62 | $0.69 | $0.85 | $1.03 |
| Dividends per share | — | — | — | — | $0.05 | $0.06 | $0.07 | — | $0.00 | $0.00 |
| Capex per share | $0.07 | $0.17 | $0.03 | $0.05 | $0.01 | $0.01 | $0.01 | $0.01 | $0.03 | $0.03 |
| Debt per share | $0.32 | $0.37 | $0.21 | $0.22 | $0.04 | $0.21 | $0.17 | — | $0.27 | $0.38 |
| Shares outstanding | 30.7M | 29.6M | 29.6M | 29.2M | 27.8M | 23.5M | 22.9M | 22.4M | 22.8M | 16.3M |
| Change in shares outstanding | +3.7% | −0.1% | +1.4% | +5.2% | +18.4% | +2.5% | +2.2% | −1.7% | +40.1% | +24.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −4.2% | −3.3% | 35.4% | 23.0% | 30.3% | −15.9% | −19.0% | −30.1% | 2.9% | −70.4% |
| Return on invested capital (ROIC) | −10.1% | −3.8% | 19.6% | 48.9% | 48.0% | −27.2% | −17.8% | −36.3% | 13.3% | −81.7% |
| Return on assets (ROA) | −3.6% | −2.8% | 29.3% | 18.1% | 22.5% | −9.6% | −13.4% | −20.0% | 1.7% | −27.6% |
| Return on tangible assets | −3.1% | −3.1% | 25.9% | 14.8% | 15.2% | −9.4% | −13.6% | −24.6% | 1.7% | −18.3% |
| Free cash flow margin | −10.8% | −21.0% | 1.5% | 13.3% | 2.1% | −17.6% | −9.8% | −27.6% | −6.5% | −26.3% |
| Income quality (OCF / net income) | — | — | 0.05 | 0.69 | 0.16 | — | — | — | −2.56 | — |
| Financial health | ||||||||||
| Total debt | $9.9M | $10.8M | $6.2M | $6.3M | $1.0M | $4.8M | $3.9M | — | $6.1M | $6.2M |
| Cash & short-term investments | $116.4M | $25.2M | $49.2M | $47.9M | $31.5M | $4.6M | $5.4M | $5.4M | $16.8M | $17.8M |
| Net debt | −$106.5M | −$14.4M | −$43.0M | −$41.6M | −$30.5M | $241,000 | −$1.5M | −$5.4M | −$10.7M | −$11.6M |
| Debt / equity | 0.05 | 0.09 | 0.06 | 0.08 | 0.02 | 0.42 | 0.28 | — | 0.32 | 0.37 |
| Debt / assets | 0.04 | 0.07 | 0.05 | 0.06 | 0.02 | 0.22 | 0.19 | — | 0.20 | 0.20 |
| Net debt / EBITDA | — | — | −3.11 | −3.01 | −3.09 | — | — | — | −8.45 | — |
| Current ratio | 10.33 | 5.68 | 9.31 | 5.46 | 5.45 | 2.12 | 4.57 | 3.63 | 2.64 | 3.73 |
| Quick ratio | 8.01 | 2.99 | 5.75 | 3.99 | 4.08 | 1.14 | 2.50 | 1.99 | 1.83 | 2.89 |
| Interest coverage | — | — | — | 10.8 | 600.0 | -90.9 | -254.5 | -17.0 | 2.3 | -7.3 |
| Working capital | $166.6M | $73.1M | $87.3M | $72.7M | $49.0M | $10.1M | $13.8M | $14.5M | $18.3M | $21.5M |
| Invested capital | $113.0M | $108.5M | $68.6M | $34.0M | $20.5M | $11.7M | $12.6M | $10.0M | $8.6M | $5.2M |
| Tangible asset value | $199.2M | $101.4M | $111.6M | $75.6M | $51.0M | $11.4M | $14.1M | $15.5M | $19.3M | $16.8M |
| Net current asset value | $157.3M | $63.1M | $81.5M | $66.5M | $48.7M | $9.0M | $11.1M | $14.2M | $17.8M | $15.3M |
| Graham number | — | — | $9.74 | $5.39 | $3.75 | — | — | — | $0.66 | — |
| Graham net-net per share | $4.01 | $1.15 | $1.99 | $1.70 | $1.34 | $0.11 | $0.25 | $0.35 | $0.52 | $0.62 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | $1.4M | $1.4M | $1.7M | — | $0 | $0 |
| Share buybacks (net) | $2.4M | $784,000 | $1.6M | $2.1M | $429,000 | $20,000 | $10,000 | $0 | $0 | $0 |
| Dividend payout ratio | — | — | — | — | 14.8% | — | — | — | 0.0% | — |
| Dividends + buybacks / free cash flow | — | — | 158.5% | 23.8% | 167.5% | — | — | — | — | — |
| Capex / revenue | 4.1% | 8.5% | 1.1% | 2.1% | 0.8% | 1.4% | 0.7% | 0.8% | 1.9% | 2.5% |
| Capex / operating cash flow | — | — | 42.7% | 13.6% | 27.6% | — | — | — | — | — |
| Capex / depreciation | 0.59 | 1.47 | 0.55 | 3.03 | 1.36 | 0.73 | 0.42 | 0.40 | 1.37 | 1.76 |
| Stock-based compensation / revenue | 13.5% | 8.8% | 3.8% | 4.2% | 5.9% | 6.6% | 4.1% | 4.3% | 3.4% | 5.3% |
| R&D / revenue | 25.3% | 17.7% | 13.2% | 11.0% | 11.4% | 22.0% | 15.2% | 19.7% | 14.1% | 24.6% |
| SG&A / revenue | 38.3% | 31.0% | 20.8% | 18.8% | 19.8% | 39.5% | 33.8% | 36.7% | 24.7% | 37.3% |
| Efficiency | ||||||||||
| Days sales outstanding | 128.7 | 86.0 | 73.3 | 82.7 | 64.8 | 98.1 | 70.2 | 66.9 | 42.4 | 43.8 |
| Days of inventory on hand | 470.2 | 413.9 | 332.6 | 220.7 | 160.6 | 290.8 | 223.5 | 245.7 | 166.4 | 205.4 |
| Days payables outstanding | 76.1 | 62.8 | 78.8 | 75.9 | 47.6 | 66.3 | 37.7 | 50.1 | 48.6 | 63.6 |
| Cash conversion cycle (days) | 522.9 | 437.1 | 327.1 | 227.5 | 177.8 | 322.6 | 256.0 | 262.4 | 160.2 | 185.6 |
| Receivables turnover | 2.84 | 4.24 | 4.98 | 4.41 | 5.63 | 3.72 | 5.20 | 5.46 | 8.61 | 8.34 |
| Payables turnover | 4.80 | 5.81 | 4.63 | 4.81 | 7.66 | 5.51 | 9.67 | 7.28 | 7.51 | 5.74 |
| Inventory turnover | 0.78 | 0.88 | 1.10 | 1.65 | 2.27 | 1.26 | 1.63 | 1.49 | 2.19 | 1.78 |
| Asset turnover | 0.25 | 0.43 | 0.59 | 0.81 | 1.21 | 0.79 | 1.06 | 0.81 | 0.96 | 0.92 |
| Average receivables | $17.6M | $13.9M | $13.3M | $14.7M | $9.0M | $4.5M | $4.3M | $3.9M | $3.4M | $2.3M |
| Average payables | $6.7M | $6.0M | $7.3M | $6.7M | $3.5M | $1.9M | $1.4M | $1.8M | $2.3M | $2.1M |
| Average inventory | $41.7M | $39.7M | $30.7M | $19.5M | $11.9M | $8.4M | $8.5M | $9.1M | $7.8M | $6.8M |
| Intangibles / total assets | 8.2% | 14.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from AEHR's annual financial statements (latest annual report filed July 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
AEHR valuation and financial ratios
Aehr Test Systems earned a return on equity of −4.2% and a return on invested capital of −10.1% in fiscal 2026. It ended the year with $9.9 million of debt and $116.4 million in cash and short-term investments, a net cash position of $106.5 million. It returned $2.4 million to shareholders: $0 in dividends and $2.4 million in share buybacks. The share count rose 88.5% from 16.3M to 30.7M over 9 years.
See the AEHR income statement, the AEHR chart for price history, or the AEHR stock overview for the latest quote and news.
AEHR key metrics FAQ
What is Aehr Test Systems's return on equity?
Aehr Test Systems's return on equity (ROE) was −4.2% in fiscal 2026: net income of -$7.1 million on average shareholders' equity of $171.2 million.
What is Aehr Test Systems's ROIC?
Aehr Test Systems's return on invested capital was −10.1% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Aehr Test Systems have?
Aehr Test Systems had total debt of $9.9 million at the end of fiscal 2026, a debt-to-equity ratio of 0.05 and more cash than debt.
Does Aehr Test Systems buy back its shares?
Yes. Aehr Test Systems spent $2.4 million on net share repurchases in fiscal 2026 Shares outstanding changed +3.7% over the year, to 30.7M..
What is Aehr Test Systems's free cash flow yield?
Aehr Test Systems generated -$5.4 million of free cash flow in fiscal 2026, a free cash flow yield of −0.2% on its market value at year-end ($2.8 billion).
What is Aehr Test Systems's current ratio?
Aehr Test Systems's current ratio was 10.33 at the end of fiscal 2026: current assets were 10.33 times current liabilities.